Skip to main content

Medical Subject Headings

Search from vocabulary

Content language

Concept information

Nucleic Acids, Nucleotides, and Nucleosides > Nucleosides > Ribonucleosides > Adenosine > Ticagrelor
... > Carbohydrates > Glycosides > Nucleosides > Ribonucleosides > Adenosine > Ticagrelor
Nucleic Acids, Nucleotides, and Nucleosides > Nucleosides > Purine Nucleosides > Adenosine > Ticagrelor
... > Carbohydrates > Glycosides > Nucleosides > Purine Nucleosides > Adenosine > Ticagrelor
... > Heterocyclic Compounds > Heterocyclic Compounds, Fused-Ring > Heterocyclic Compounds, 2-Ring > Purines > Purine Nucleosides > Adenosine > Ticagrelor

Preferred term

Ticagrelor  

Type

  • Topical Descriptor

Broader concept

Entry terms

  • 3-(7-((2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-(1-3)-triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
  • AZD 6140
  • Brilinta
  • Brilique

Scope note

  • An adenosine triphosphate analogue and reversible P2Y12 PURINORECEPTOR antagonist that inhibits ADP-mediated PLATELET AGGREGATION. It is used for the prevention of THROMBOEMBOLISM by patients with ACUTE CORONARY SYNDROME or a history of MYOCARDIAL INFARCTION.

History note

  • 2019 (2005)

In other languages

URI

http://www.yso.fi/onto/mesh/D000077486

Download this concept:

RDF/XML TURTLE JSON-LD Created 7/9/18, last modified 6/19/18